An article in the October 2019 edition of RADAR on Specialty Pharmacy published by AIS Health highlighted North Memorial Health’s successful specialty pharmacy program partnership with Trellis Rx. Read the full article below.
PART 1: DESCRIBING THE PROBLEM OF NO OBSTRUCTIVE CORONARY ARTERY DISEASE IN PATIENTS WITH ANGINA SYMPTOMS FOR WHICH THE CAUSE NEEDS TO BE INVESTIGATEDBackgroundAlmost half of patients with symptoms of angina pectoris have no obstructive coronary artery disease (NOCAD) revealed by coronary angiography. Many of these patients have a normal or near normal coronary angiogram.
Harvard Pilgrim Health Care, Inc. continues to add to its value-based arrangements with new deals for two specialty drugs. The insurer said Feb. 22 it had signed outcomes-based contracts with Amgen Inc. for its anti-inflammatory treatment Enbrel (etanercept) and Eli Lilly and Co. for its osteoporosis medication Forteo (teriparatide). As costs for specialty drugs in particular continue to rise, payers are looking beyond traditional management tactics to keep spending in check.